Synthesis of a DNA-targeting nickel (II) complex with testosterone thiosemicarbazone which exhibits selective cytotoxicity towards human prostate cancer cells (LNCaP)
2014
Zn(II), Cu(II), and Ni(II) Schiff base complexes as topoisomerase I inhibitors having antiproliferative and anti-metastatic properties.